{"id":"tp-59403","type":"article-newspaper","title":"Purple Biotech Posts $0.51 Third-Quarter GAAP Loss Per Share","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/59403","datePublished":"2026-11-17T13:08:48.000Z","dateModified":"2026-11-17T13:08:48.000Z","language":"en","abstract":"The company held $5.1 million in cash, cash equivalents and short-term deposits as of Sept. 30, 2026, with a projected runway through late 2027.","section":"Business","references":[]}